VC-backed Kala taps Iwicki as executive chairman

Waltham, Massachusetts-based Kala Pharmaceuticals, a developer of treatments for ocular diseases, has named Mark Iwicki as executive chairman and a member of its board of directors. Previously, Iwicki was the president and CEO of Civitas Therapeutics Inc. Kala's backers include Crown Venture Fund, Lux Capital, Polaris Partners, Third Rock Ventures and Ysios Capital.

PeopleNorth AmericaUSBriefs